⌘K

Login Start Free

Home/Filings/6-K/0001213900-25-087068

6-K//Foreign company update

LakeShore Biopharma Co., Ltd. 6-K

Accession 0001213900-25-087068

$LSBCFCIK 0001946399other

View on SEC.gov Company Profile

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 9:05 AM ET

Size

21.5 KB

Accession

0001213900-25-087068

Documents

2 files

6-K
ea0257151-6k_lakeshore.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea025715101ex99-1_lakeshore.htm
PRESS RELEASE - LAKESHORE BIOPHARMA ANNOUNCES RECEIPT OF DELISTING DETERMINATION LETTER FROM NASDAQ

Issuer

LakeShore Biopharma Co., Ltd.

CIK 0001946399

Entity typeother

IncorporatedCayman Islands

Related Parties

1

filerCIK 0001946399

Filing Metadata

Form type: 6-K
Filed: Sep 11, 8:00 PM ET
Accepted: Sep 12, 9:05 AM ET
Size: 21.5 KB

View on SEC.gov